Literature DB >> 8591816

Insulin resistance in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a new model of NIDDM.

T Sato1, Y Asahi, K Toide, N Nakayama.   

Abstract

The Otsuka Long-Evans Tokushima Fatty rat is a new inbred obese strain with a late onset and chronic course of spontaneous hyperglycaemia in the male, and is considered to be a model of non-insulin-dependent diabetes mellitus [1, 2]. Fat distribution analysis showed a typical accumulation of intra-abdominal visceral fat in Otsuka Long-Evans Tokushima Fatty rats compared with a control strain, Long-Evans Tokushima Otsuka rats. To examine the insulin sensitivity of Otsuka Long-Evans Tokushima Fatty rats, we performed euglycaemic hyperinsulinaemic clamp experiments in vivo in rats under anaesthesia on this strain and on Long-Evans Tokushima Otsuka rats. The Otsuka Long-Evans Tokushima Fatty rats showed lower values for the glucose infusion rate (60% of the control at 12 weeks old and 20-30% of the control at 18, 24, 30 and 39 weeks old) than age-matched controls, indicating the development of insulin resistance with age. Hindlimb perfusion experiments in vitro also showed a 45% decrease of insulin-stimulated glucose uptake in Otsuka Long-Evens Tokushima Fatty rats in the diabetic stage. These results indicate that insulin resistance exists in the skeletal muscle of Otsuka Long-Evans Tokushima Fatty rats. To obtain information on the mechanism of insulin resistance in the skeletal muscle of Otsuka Long-Evans Tokushima Fatty rats, the insulin binding, autophosphorylation and tyrosine kinase activity of their partially-purified insulin receptors in vitro were compared with those from control rats. The results showed no marked differences in these insulin receptor functions between diabetic and control rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591816     DOI: 10.1007/bf00402172

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.

Authors:  J F Caro; M K Sinha; S M Raju; O Ittoop; W J Pories; E G Flickinger; D Meelheim; G L Dohm
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

4.  Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes.

Authors:  P Vicario; E J Brady; E E Slater; R Saperstein
Journal:  Life Sci       Date:  1987-09-07       Impact factor: 5.037

5.  Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle.

Authors:  C F Burant; M K Treutelaar; M G Buse
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

6.  Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.

Authors:  B L Nyomba; V M Ossowski; C Bogardus; D M Mott
Journal:  Am J Physiol       Date:  1990-06

7.  Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes.

Authors:  J Svedberg; P Björntorp; U Smith; P Lönnroth
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

8.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus.

Authors:  B Obermaier-Kusser; M F White; D E Pongratz; Z Su; B Ermel; C Muhlbacher; H U Haring
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

9.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose.

Authors:  L Ellis; E Clauser; D O Morgan; M Edery; R A Roth; W J Rutter
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

10.  Phosphorylation of insulin receptors solubilized from rat skeletal muscle.

Authors:  C F Burant; M K Treutelaar; G E Landreth; M G Buse
Journal:  Diabetes       Date:  1984-07       Impact factor: 9.461

View more
  12 in total

1.  Voluntary wheel running selectively augments insulin-stimulated vasodilation in arterioles from white skeletal muscle of insulin-resistant rats.

Authors:  Catherine R Mikus; Bruno T Roseguini; Grace M Uptergrove; E Matthew Morris; Randy Scott Rector; Jessica L Libla; Douglas J Oberlin; Sarah J Borengasser; Angelina M Taylor; Jamal A Ibdah; Maurice Harold Laughlin; John P Thyfault
Journal:  Microcirculation       Date:  2012-11       Impact factor: 2.628

2.  Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis.

Authors:  Takahiro Minato; Mikihiro Tsutsumi; Mutsumi Tsuchishima; Nobuhiko Hayashi; Takashi Saito; Yasuhiro Matsue; Nobuyuki Toshikuni; Tomiyasu Arisawa; Joseph George
Journal:  Mol Med       Date:  2014-12-10       Impact factor: 6.354

3.  Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart.

Authors:  T Hayashi; K Sohmiya; A Ukimura; S Endoh; T Mori; H Shimomura; M Okabe; F Terasaki; Y Kitaura
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

4.  Short-term effect of bezafibrate on the expression of adiponectin mRNA in the adipose tissues: a study in spontaneously type 2 diabetic rats with visceral obesity.

Authors:  Yutaka Mori; Fumiki Oana; Akane Matsuzawa; Satoshi Akahane; Naoko Tajima
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

5.  Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Kosuke Kaji; Yasuhide Ikenaka; Yusaku Shirai; Tadashi Namisaki; Mitsuteru Kitade; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2009-11-26       Impact factor: 7.527

6.  Inhibition of γ-glutamyltransferase ameliorates ischaemia-reoxygenation tissue damage in rats with hepatic steatosis.

Authors:  Ryuichi Kubota; Nobuhiko Hayashi; Kaori Kinoshita; Takashi Saito; Kazuaki Ozaki; Yoshimichi Ueda; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Joseph George
Journal:  Br J Pharmacol       Date:  2020-10-19       Impact factor: 8.739

7.  Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

Authors:  Hitoshi Yoshiji; Ryuichi Noguchi; Mitsuteru Kitade; Kosuke Kaji; Yasuhide Ikenaka; Tadashi Namisaki; Junichi Yoshii; Koji Yanase; Masaharu Yamazaki; Tatsuhiro Tsujimoto; Takemi Akahane; Hideto Kawaratani; Masahito Uemura; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2009-03-25       Impact factor: 7.527

8.  Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.

Authors:  Norihisa Nishimura; Mitsuteru Kitade; Ryuichi Noguchi; Tadashi Namisaki; Kei Moriya; Kosuke Takeda; Yasushi Okura; Yosuke Aihara; Akitoshi Douhara; Hideto Kawaratani; Kiyoshi Asada; Hitoshi Yoshiji
Journal:  J Gastroenterol       Date:  2016-03-29       Impact factor: 7.527

Review 9.  Therapeutic effects of sericin on diabetic keratopathy in Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Noriaki Nagai; Yoshimasa Ito
Journal:  World J Diabetes       Date:  2013-12-15

10.  Dysregulation of dimethylargininedimethylaminohydrolase/asymmetric dimethylarginine pathway in rat type II diabetic nephropathy.

Authors:  Ying-Ling Lai; Sae Aoyama; Miyuki Ohata; Nami Otsuka; Hidemi Shiokawa; Susumu Tomono; Yukio Fujiwara; Hiroaki Kanazawa; Noriyuki Miyoshi; Hiroshi Ohshima
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.